Salk Talk - Salk Institute For Biological Studies

Reuben Shaw is a professor and the director of the Salk Cancer Center. Fifteen years ago, he discovered that a gene frequently mutated in cancer (LKB1) regulates an enzyme named AMPK. Ever since, he has been studying the AMPK pathway to see if drugs originally designed to treat metabolic diseases could also work against cancer. On this episode of Where Cures Begin, Shaw talks about his initial discovery; what it’s like running the Salk Cancer Center; and his continual drive to study the hardest-to-treat cancers.